{"id":171272,"date":"2017-05-15T14:49:34","date_gmt":"2017-05-15T14:49:34","guid":{"rendered":"https:\/\/wordpress-693215-2610341.cloudwaysapps.com\/index.php\/2017\/05\/15\/11th-otc-derivatives-summit-the-annual-meeting-of-the-global-fixed-income-institute-at-pennyhill-park-hotel\/"},"modified":"2017-05-15T14:49:34","modified_gmt":"2017-05-15T14:49:34","slug":"11th-otc-derivatives-summit-the-annual-meeting-of-the-global-fixed-income-institute-at-pennyhill-park-hotel","status":"publish","type":"post","link":"https:\/\/theotcspace.com\/11th-otc-derivatives-summit-the-annual-meeting-of-the-global-fixed-income-institute-at-pennyhill-park-hotel\/","title":{"rendered":"11th OTC Derivatives Summit: The Annual Meeting of the Global Fixed Income Institute at Pennyhill Park Hotel"},"content":{"rendered":"

The OTC Derivatives Summit of the Global Fixed Income Institute<\/em> is an annual event which has now been running for over ten years. Those in the know refer to the Summit informally as the Pennyhill Park event – where a group of the most senior buy- and sell-side individuals debate (in private) the latest challenges running an OTC derivatives business.<\/p>\n

<\/p>\n

11th OTC Derivatives Summit<\/h2>\n

The Annual Meeting of the Global Fixed Income Institute<\/h2>\n

Thursday 13th & Friday 14th July, 2017: Pennyhill Park Hotel, Bagshot, Surrey<\/h2>\n

The OTC Derivatives Summit of the Global Fixed Income Institute<\/em> is an annual event which has now been running for over ten years. Those in the know refer to the Summit informally as the Pennyhill Park event – due to the venue. For the past four years the Fixed Income Forum<\/em> has also been running a parallel event in the US with the same goals.<\/p>\n

Both events are private, invitation-only and dedicated to the concerns of the asset management buy side. They attract the leading stakeholders in the industry in a highly collegial environment featuring totally frank and objective exchanges of information and ideas. Agendas are driven by an Advisory Board who provide their input to define the most pressing and intractable problems needing consideration and debate.<\/p>\n

Speakers will include:<\/p>\n

    \n
  • Andy Ross: Chief Executive Officer, CurveGlobal<\/strong><\/li>\n
  • Aviv Handler: Independent Consultant<\/li>\n
  • Bill Hodgson: Independent Consultant, The OTC Space<\/strong><\/li>\n
  • Brian Lynch: Co-founder and CEO, RegTek Solutions<\/strong><\/li>\n
  • Daniel J. Maguire: Group Chief Operating Officer & Global Head of Rates & FX Derivatives, LCH<\/strong><\/li>\n
  • David Bullen: Independent Consultant, Bullen Management<\/strong><\/li>\n
  • David Field: The Field Effect<\/strong><\/li>\n
  • Eileen Herlihy: EMEA Head of Derivatives Clearing Sales, JP Morgan Chase<\/strong><\/li>\n
  • Gavin Platman: Head of Operations Strategy, Insight Investment<\/strong><\/li>\n
  • Ila Eckhoff: Managing Director, Blackrock<\/strong><\/li>\n
  • John Lund: Independent Consultant, JXL Consulting<\/strong><\/li>\n
  • Karen Singerman: Associate Director, GFII<\/strong><\/li>\n
  • Kay Swinburne MEP: Vice Chairman Committee on Economic and Monetary Affairs<\/li>\n
  • Liz Carter: Managing Director, Trade Processing and Clearing, Tradeweb<\/strong><\/li>\n
  • Mark Barnard: Independent Consultant<\/li>\n
  • Mark Beeston: Partner, Illuminate Financial<\/strong><\/li>\n
  • Mark Woodward: VP, Corporate Development, ICE Clear Europe<\/strong><\/li>\n
  • Michael Wellenbeck: Independent Consultant, Wellenbeck Advisory Services<\/strong><\/li>\n
  • Neil Murphy: Business Manager triResolve, TriOptima<\/strong><\/li>\n
  • Phil Hermon: OTC Products, CME Group<\/strong><\/li>\n
  • Ricky Maloney: Front Office Business Manager, Old Mutual Global Investors<\/strong><\/li>\n
  • Robin Moody: Business Lead, SmartDX<\/strong><\/li>\n
  • Russ Oxley: Independent Consultant<\/li>\n
  • Simon Onyons: Principal Cyber Specialist, Financial Conduct Authority<\/strong><\/li>\n
  • Steven Griffiths: Independent Consultant, Absolute Derivatives<\/strong><\/li>\n
  • Ted Leveroni: Chief Commercial Officer, DTCC-Euroclear Global Collateral Ltd<\/strong><\/li>\n
  • Timothy Jarvis: Vice President OTC Product Development, Bank of America Merrill Lynch<\/strong><\/li>\n
  • Tracey Jordal: Executive Vice President, Senior Counsel, PIMCO<\/strong><\/li>\n
  • Vj Angelo: Chief Executive Officer, London Derivatives Exchange<\/strong><\/li>\n<\/ul>\n

    Thursday 13th July – Day 1<\/h2>\n

    \"\"<\/p>\n

    Friday 14th July – Day 2<\/h2>\n

    \"\"<\/p>\n

    \"Pennyhill<\/p>\n